// App-Quantinova.ai

P590 : Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel

Researchers

Presenter

  • Hansen, R

Principal Investigators

  • Torrente, F

  • Kammermeier, J

  • Croft, N.M

  • de Ridder, L

  • Wilson, D.C

  • Klomberg, R

  • Turner, D

  • Martn-de-Carpi, J

  • Bronsky, J

  • Benchimol, E

  • Amil-Dias, J

  • Mack, D.R

  • Walker, G

  • Powar, M

  • Burgess, N

  • van Ommen, C.H

  • Irving, P.M

  • Samaan, M

Medical Centers

  • Royal Hospital for Children, Department of Paediatric Gastroenterology, Glasgow, United Kingdom

  • Royal Free London NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom

  • Cambridge University Hospitals, Department ofPaediatric Gastroenterology, Cambridge, United Kingdom

  • The Royal London Hospital, Department of Paediatric Gastroenterology, London, United Kingdom

  • Queen Mary University of London, Centre for Immunobiology- Blizard Institute, London, United Kingdom

  • Childrens Hospital Erasmus MC Sophia, Department of Paediatric Gastroenterology, Rotterdam, Netherlands

  • University Of Edinburgh, Department of Child Life and Health, Edinburgh, United Kingdom

  • Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Pediatric Gastroenterology, Jerusalem, Israel

  • Hospital Sant Joan de Deu, Department of Gastroenterology, Hepatology and Pediatric Nutrition, Barcelona, Spain

  • Motol University Hospital, Department of Pediatrics, Prague, Czech Republic

  • The Hospital for Sick Children- University of Toronto, Division of Gastroenterology- Hepatology and Nutrition- Department of Paediatrics, Toronto, Canada

  • Hospital Lusíadas, Department of Pediatric Gastroenterology, Porto, Portugal

  • Children's Hospital of Eastern Ontario IBD Centre, University of Ottawa, Department of Pediatrics, Ottawa, Canada

  • Royal Hospital for Children, Department of Paediatric Gastroenterology, Glasgow, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, and Cambridge Breast Unit, Cambridge, United Kingdom

  • The Royal London Hospital, Department of Paediatric Gastroenterology, London, United Kingdom

  • Sophia Children's Hospital Erasmus MC, Department of Paediatric Hematology-Oncology, Rotterdam, The Netherlands

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

  • Netherlands

  • Israel

  • Spain

  • Czech Republic

  • Canada

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A